(HealthDay News) — For women with cardiovascular conditions, long-acting reversible contraception appears safe with few complications, according to a study published in The American Journal of Cardiology.

Quyen Vu, from the University of Washington School of Medicine in Seattle, and colleagues conducted a retrospective chart review of 470 women diagnosed with cardiovascular disease who had a copper intrauterine device (IUD), levonorgestrel-releasing intrauterine system, or contraceptive implant. 

Patient demographic characteristics, medical conditions, indications from long-acting reversible contraceptive placement, and complications were abstracted and analyzed.


Continue Reading

The researchers found that 87.23% of women chose the levonorgestrel-releasing intrauterine system, 7.02% chose the copper IUD, and 4.89% chose the etonogestrel implant. Overall, 3.83% of patients had a confirmed IUD expulsion, 0.43% became pregnant, and 0.85% had pelvic inflammatory disease. No cases of perforation were reported. No confirmed cases of infective endocarditis linked to long-acting reversible contraceptive insertion were reported.

“[Long-acting reversible contraception] devices appear safe with few complications for women with cardiovascular conditions,” the researchers wrote. “Clinicians can be reassured that [long-acting reversible contraception] may be offered as an appropriate option when counseling women with cardiovascular disease on safe contraceptive methods.”

Reference

  1. Vu Q, Micks E, McCoy E, Prager S. Efficacy and Safety of Long-Acting Reversible Contraception in Women With Cardiovascular Conditions. Am J Cardiol. 2016;117(2):302-304. doi:10.1016/j.amjcard.2015.10.026.